Drugs -- Social aspects -- History. / https://id.loc.gov/authorities/subjects/sh85039719 https://id.loc.gov/authorities/subjects/sh00002758 https://id.loc.gov/authorities/subjects/sh99005024 : Escohotado, Antonio.
1999
1
Drugs -- Social aspects -- United States.
3
1
Drugs -- Standards.
3
Drugs -- Standards -- International cooperation. / https://id.loc.gov/authorities/subjects/sh85039748 https://id.loc.gov/authorities/subjects/sh00006352 : United States,
2013
1
Drugs -- Standards -- Reform. / https://id.loc.gov/authorities/subjects/sh85039748 https://id.loc.gov/authorities/subjects/sh00007584 : Schlenkrich, Sara,
2015
1
Drugs -- Standards -- United States. / https://id.loc.gov/authorities/subjects/sh2009123923 : Clinton, Bill,
1995
1
Drugs -- Storage. : Simpson, Michelle.
2022
1
Drugs -- Structure-activity relationships.
5
Drugs -- Structure-activity relationships -- Mathematical models. / https://id.loc.gov/authorities/subjects/sh85039752 https://id.loc.gov/authorities/subjects/sh2002007921 : Purcell, William P.
1973
1
Here are entered works on means used to insure drug delivery to desired anatomical sites or lesions.
1
Drugs -- Taxation -- Law and legislation. : Stebbings, Chantal,
2017
1
Drugs Testing -- See Also the narrower term Drug monitoring Here are entered works on the process of observing, recording, or detecting the effects of a drug administered therapeutically or diagnostically to an individual. Works on the detection of adverse effects of medicines in the general population are entered under Pharmacovigilance.
1
Drugs -- Testing.
15
Drugs -- Testing -- Congresses.
3
Drugs -- Testing -- Drama.
2
Drugs -- Testing -- Economic aspects -- United States.
2
Drugs -- Testing -- Fiction. / https://id.loc.gov/authorities/subjects/sh85039755 https://id.loc.gov/authorities/subjects/sh99001562 : Carleson, J. C.,
2015
1
Drugs -- Testing -- Government policy. / https://id.loc.gov/authorities/subjects/sh85039755 https://id.loc.gov/authorities/subjects/sh99005269
2020
1
Drugs -- Testing -- Government policy -- United States.
2
Drugs -- Testing -- Government policy -- United States -- Congresses. / https://id.loc.gov/authorities/subjects/sh85039755 https://id.loc.gov/authorities/subjects/sh99005269 https://id.loc.gov/authorities/names/n78095330-781 https://id.loc.gov/authorities/subjects/sh99001533 : Caruso, Denise,
2014
1
Drugs -- Testing -- Law and legislation. / https://id.loc.gov/authorities/subjects/sh88003050 : Sampath, Padmashree Gehl.
2005
1
Drugs -- Testing -- Law and legislation -- United States. / https://id.loc.gov/authorities/subjects/sh88003050 https://id.loc.gov/authorities/names/n78095330-781
2008
1
Drugs -- Testing -- Law and legislation -- United States -- Congresses. / https://id.loc.gov/authorities/subjects/sh88003050 https://id.loc.gov/authorities/names/n78095330-781 https://id.loc.gov/authorities/subjects/sh99001533 : Caruso, Denise,
2014
1
Drugs -- Testing -- Moral and ethical aspects. / https://id.loc.gov/authorities/subjects/sh85039755 https://id.loc.gov/authorities/subjects/sh00006099 : Petryna, Adriana,
2009
1
Drugs -- Testing -- Moral and ethical aspects -- United States.
3
Drugs -- Testing -- Safety measures. / https://id.loc.gov/authorities/subjects/sh85039755 https://id.loc.gov/authorities/subjects/sh00007912
2004
1
Drugs -- Testing -- Standards. / https://id.loc.gov/authorities/subjects/sh85039755 https://id.loc.gov/authorities/subjects/sh00007508 : Weisfeld, Victoria D.,
2013
1
Drugs -- Therapeutic equivalency. / https://id.loc.gov/authorities/subjects/sh85039756 : McPherson, Mary Lynn M.,
2018
1
Drugs -- Therapeutic equivalency -- Databases. / https://id.loc.gov/authorities/subjects/sh85039756 https://id.loc.gov/authorities/subjects/sh99001528
200-
1
Drugs -- Therapeutic equivalency -- Periodicals. / https://id.loc.gov/authorities/subjects/sh85039756 https://id.loc.gov/authorities/subjects/sh99001647
1985
1
Drugs -- Therapeutic use.
2
1
Drugs -- Toxicology.
2
Drugs -- Toxicology -- Congresses. / https://id.loc.gov/authorities/subjects/sh2009123931 : Symposium on the Poisoned Patient: the Role of the Laboratory
1974
1
Drugs -- Toxicology -- Prevention -- Congresses. / https://id.loc.gov/authorities/subjects/sh85039757 https://id.loc.gov/authorities/subjects/sh99002416 https://id.loc.gov/authorities/subjects/sh99001533
2011
1
Drugs -- Toxicology -- Risk assessment. / https://id.loc.gov/authorities/subjects/sh85039757 https://id.loc.gov/authorities/subjects/sh00006258 : United States.
2012
1
Drugs -- United States.
4
Drugs -- United States -- Administration. / https://id.loc.gov/authorities/subjects/sh85039719 https://id.loc.gov/authorities/names/n78095330-781 https://id.loc.gov/authorities/subjects/sh2002007910
2016
1
Drugs -- United States -- Cost control.
2
Drugs -- United States -- Design.
2
Drugs -- United States -- Design -- Congresses.
2
Drugs -- United States -- Finance. / https://id.loc.gov/authorities/subjects/sh85039719 https://id.loc.gov/authorities/names/n78095330-781 https://id.loc.gov/authorities/subjects/sh2002007885 : United States.
2022
1
Drugs -- United States -- History.
2
Drugs -- United States -- Marketing.
2
Drugs -- United States -- Marketing -- Congresses. / https://id.loc.gov/authorities/subjects/sh2009123359 https://id.loc.gov/authorities/subjects/sh99001533 : Library of Congress.
1979
1
Drugs -- United States -- Patents.
5
Drugs -- United States -- Regulations -- Congresses. / https://id.loc.gov/authorities/subjects/sh85039719 https://id.loc.gov/authorities/names/n78095330-781 https://id.loc.gov/authorities/subjects/sh99002105 https://id.loc.gov/authorities/subjects/sh99001533
2012
1
Drugs -- United States -- Safety measures. / https://id.loc.gov/authorities/subjects/sh85039719 https://id.loc.gov/authorities/names/n78095330-781 https://id.loc.gov/authorities/subjects/sh00007912 : United States.
2012
1
Drugs -- United States -- Safety measures -- Congresses.
2
Save Marked Records
Save to List